CASI Pharmaceuticals (CASI) News Today

$7.04

-0.46 (-6.13%)

(As of 12/8/2023 ET)

Today's Range: $6.10
▼
$8.36
50-Day Range: $2.62
▼
$7.50
52-Week Range: $1.45
▼
$8.36

Volume: 268,287 shs
Average Volume: N/A
Market Capitalization: $93.77 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $12.00

Source

Source	Headline
	CASI Pharmaceuticals (NASDAQ:CASI) Earns Hold Rating from Analysts at StockNews.com americanbankingnews.com - December 7 at 1:22 AM
	HC Wainwright & Co. Maintains Buy Rating for CASI Pharmaceuticals: Here's What You Need To Know markets.businessinsider.com - November 15 at 1:58 PM
	CASI Pharmaceuticals Posts Narrower Loss In Q3 markets.businessinsider.com - November 14 at 10:21 AM
	CASI Pharmaceuticals GAAP EPS of -$0.35, revenue of $8.84M msn.com - November 14 at 10:21 AM
	CASI PHARMACEUTICALS ANNOUNCES THIRD QUARTER 2023 BUSINESS AND FINANCIAL UPDATES finance.yahoo.com - November 14 at 10:21 AM
	CASI : Juventas' CNCT 19 Approved In China For R/R B-cell Acute Lymphoblastic Leukemia Treatment markets.businessinsider.com - November 8 at 8:33 AM
	H.C. Wainwright Sticks to Its Buy Rating for CASI Pharmaceuticals (CASI) markets.businessinsider.com - August 14 at 9:43 AM
	CASI Pharmaceuticals, Inc. Q2 Loss Widens markets.businessinsider.com - August 11 at 6:11 PM
	CASI Pharmaceuticals GAAP EPS of -$0.77, revenue of $9.82M msn.com - August 11 at 6:11 PM
	CASI PHARMACEUTICALS ANNOUNCES SECOND QUARTER 2023 BUSINESS AND FINANCIAL UPDATES finance.yahoo.com - August 11 at 6:11 PM
	Ionis Pharmaceuticals (IONS) Q2 Earnings and Revenues Surpass Estimates (Revised) msn.com - August 10 at 5:10 PM
	ProPhase Labs, Inc. (PRPH) Reports Q2 Loss, Lags Revenue Estimates msn.com - August 10 at 11:06 AM
	Mundipharma International Corporation Limited, Mundipharma Medical Company, and Acrotech Biopharma Inc. Enter Agreement to Transfer License of FOLOTYN® (Pralatrexate) in China to CASI Pharmaceuticals finance.yahoo.com - August 1 at 7:28 PM
	Cleave Therapeutics Announces Acquisition of Clinical and Preclinical Assets finance.yahoo.com - July 20 at 8:35 AM
	CASI Pharmaceuticals Acquires Global Intellectual Property Rights to Cleave Therapeutics' VCP/P97 Inhibitor CB-5339 finance.yahoo.com - July 20 at 8:35 AM
	Switch Therapeutics Appoints Douglas Fambrough, Ph.D., to Board of Directors finance.yahoo.com - July 10 at 8:11 AM
	CASI - CASI Pharmaceuticals, Inc. finance.yahoo.com - June 28 at 8:27 PM
	We Think CASI Pharmaceuticals (NASDAQ:CASI) Needs To Drive Business Growth Carefully finance.yahoo.com - May 28 at 10:37 AM
	CASI Pharmaceuticals, Inc. Announces First Quarter 2023 Financial Results finanznachrichten.de - May 17 at 8:52 AM
	CASI PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2023 FINANCIAL RESULTS finance.yahoo.com - May 17 at 8:52 AM
	Analysts Offer Insights on Healthcare Companies: Aurinia Pharmaceuticals (AUPH) and Cytosorbents (CTSO) markets.businessinsider.com - May 3 at 7:26 AM
	CASI Pharmaceuticals GAAP EPS of -$3.01 misses by $2.64, revenue of $43.12M beats by $32.31M msn.com - April 26 at 2:43 PM
	CASI Pharmaceuticals Files Annual Report on Form 20-F for Fiscal Year 2022 finance.yahoo.com - April 26 at 2:43 PM
	CASI PHARMACEUTICALS ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2022 FINANCIAL RESULTS finance.yahoo.com - April 26 at 9:42 AM
	Improved Revenues Required Before CASI Pharmaceuticals, Inc. (NASDAQ:CASI) Stock's 114% Jump Looks Justified finance.yahoo.com - April 17 at 7:37 AM
	Will CASI Pharmaceuticals Inc (CASI) Outperform the Rest of the Stocks in the Healthcare Sector? benzinga.com - April 12 at 10:40 PM
	Lisinopril Market Top Players and Forecast till 2031 marketwatch.com - March 23 at 9:16 AM
	CASI Pharmaceuticals, Inc. Completes Redomiciliation Merger finanznachrichten.de - March 22 at 7:48 AM
	Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size 2023 Research Report by Growth Rate Analysis and Forecast till 2027 marketwatch.com - March 17 at 7:51 PM
	Tumor Necrosis Factor Inhibitors Market Size 2023 - 2030: About its Application, Qrganization Size, Sales Volume, and Regional Outlook marketwatch.com - March 13 at 7:21 AM
	Foghorn Therapeutics Inc. (FHTX) Reports Q4 Loss, Lags Revenue Estimates msn.com - March 9 at 5:57 PM
	BTIG Reaffirms Their Hold Rating on MEI Pharma (MEIP) markets.businessinsider.com - February 14 at 7:10 AM
	A CASI Pharmaceuticals, Inc. (NASDAQ:CASI) insider increased their holdings by 16% last year finance.yahoo.com - February 6 at 10:25 AM
	H.C. Wainwright Keeps Their Buy Rating on Verastem (VSTM) markets.businessinsider.com - January 30 at 8:48 AM
	Marginal Zone B-cell Lymphoma Drugs Market Size, Outlook, Share, Prominent Players, Growth, and Forecast 2029 marketwatch.com - January 18 at 9:50 AM
	CASI PHARMACEUTICALS AND CLEAVE THERAPEUTICS ANNOUNCE CLINICAL TRIAL APPLICATION APPROVAL FOR CB-5339 IN PATIENTS WITH MULTIPLE MYELOMA IN CHINA finance.yahoo.com - January 6 at 9:20 AM
	Casi Pharmaceuticals to run clinical trial for multiple myeloma drug in China finance.yahoo.com - January 6 at 9:20 AM
	Analysis of Ibritumomab Tiuxetan Market for the Period 2023 to 2028 : Development, Growth and Key Factors marketwatch.com - January 5 at 7:57 AM
	Chinese pharmas and biotechs risk of delisting averted as US regulators review audits msn.com - December 16 at 6:42 PM
	CASI PHARMACEUTICALS' PARTNER JUVENTAS ANNOUNCES NEW DRUG APPLICATION FOR CNCT19 ACCEPTED BY CHINA NATIONAL MEDICAL PRODUCTS ADMINISTRATION finance.yahoo.com - December 15 at 7:39 AM
	CASI Pharmaceuticals Third Quarter 2022 Earnings: Beats Expectations finance.yahoo.com - November 17 at 6:50 AM
	CASI PHARMACEUTICALS ANNOUNCES THIRD QUARTER 2022 FINANCIAL RESULTS finance.yahoo.com - November 14 at 11:05 AM
	CASI Pharmaceuticals, Inc. (CASI) Reports Q3 Loss, Lags Revenue Estimates finance.yahoo.com - November 14 at 11:05 AM
	Scynexis (SCYX) Reports Q3 Loss, Misses Revenue Estimates nasdaq.com - November 9 at 11:30 AM
	Casi Pharmaceuticals forbes.com - October 7 at 3:52 PM
	CASI Pharmaceuticals Exits Juventas Biotechnology Investment marketwatch.com - September 23 at 8:42 AM
	CASI PHARMACEUTICALS ANNOUNCES EXIT OF JUVENTAS INVESTMENT TO STRENGTHEN BALANCE SHEET finance.yahoo.com - September 23 at 8:42 AM
	CASI Pharmaceuticals Earnings Perspective: Return On Capital Employed msn.com - September 9 at 10:50 AM
	Wednesday 9/7 Insider Buying Report: JELD, CASI nasdaq.com - September 7 at 6:02 PM
	CASI PHARMACEUTICALS AND BIOINVENT ANNOUNCE DOSING OF FIRST PATIENT IN BI-1206 PHASE 1 CLINICAL TRIAL FOR THE TREATMENT OF RELAPSED/REFRACTORY NON-HODGKIN'S LYMPHOMA IN CHINA finance.yahoo.com - September 7 at 8:00 AM

Get CASI Pharmaceuticals News Delivered to You Automatically

CASI Media Mentions By Week

CASI Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CASI
News Sentiment
▼
0.25

0.51
▲
Average
Medical
News Sentiment

CASI News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CASI Articles
This Week
▼
1

0
▲
CASI Articles
Average Week

Get CASI Pharmaceuticals News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:CASI) was last updated on 12/9/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

CASI Pharmaceuticals (CASI) News Today

CASI Media Mentions By Week

CASI Media Sentiment

CASI News Coverage

Related Companies and Tools

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info